Association between High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study
Open Access
- 4 June 2021
- journal article
- research article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2021, 1-6
Abstract
Background. This study aimed to explore the association between high-density lipoprotein cholesterol to apolipoprotein A-I ratio (HDL-C/apo A-I) and nonalcoholic fatty liver disease (NAFLD). Methods. A total of 9025 Chinese adults were enrolled in this cross-sectional study, who presented their annual health checkups at Zhenhai Lianhua Hospital, Ningbo, during 2017. Results. The NAFLD prevalence was 33.7%, and HDL-C/apo A-I was significantly decreased in NAFLD patients, as well as in lean NAFLD and in patients with NAFLD-related advanced fibrosis (all ). The prevalence of NAFLD and components of metabolic syndrome are inversely associated with HDL-C/apo A-I ( ). Multivariate logistic regression analysis show that HDL-C/apo A-I is inversely associated with the risk of NAFLD (odds ratio: 0.353, 95% confidence interval: 0.257–0.486; ). Conclusions. Our results suggested that increased HDL-C/apo A-I is significantly associated with a decreased risk of NAFLD.Keywords
Funding Information
- Key Research and Development Program of Zhejiang Province (2020C03033, 81722009, 81770573, 2018YFA0109800)
- National Natural Science Foundation of China (2020C03033, 81722009, 81770573, 2018YFA0109800)
- National key research and development program (2020C03033, 81722009, 81770573, 2018YFA0109800)
This publication has 40 references indexed in Scilit:
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2020
- Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016Journal of Internal Medicine, 2020
- Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisHepatology, 2019
- Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐AnalysisHepatology, 2019
- Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)Journal of Digestive Diseases, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology, 2017
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysisHepatology, 2017
- Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai StudyAmerican Journal of Gastroenterology, 2013
- Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery DiseaseDigestive Diseases and Sciences, 2011